KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Inventory Average (2018 - 2025)

Historic Inventory Average for Aquestive Therapeutics (AQST) over the last 8 years, with Q3 2025 value amounting to $8.0 million.

  • Aquestive Therapeutics' Inventory Average rose 1445.63% to $8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.0 million, marking a year-over-year increase of 1445.63%. This contributed to the annual value of $6.4 million for FY2024, which is 210.38% up from last year.
  • As of Q3 2025, Aquestive Therapeutics' Inventory Average stood at $8.0 million, which was up 1445.63% from $7.7 million recorded in Q2 2025.
  • Over the past 5 years, Aquestive Therapeutics' Inventory Average peaked at $8.0 million during Q3 2025, and registered a low of $2.6 million during Q1 2021.
  • Moreover, its 5-year median value for Inventory Average was $6.5 million (2023), whereas its average is $5.8 million.
  • In the last 5 years, Aquestive Therapeutics' Inventory Average tumbled by 1153.72% in 2021 and then soared by 10576.99% in 2022.
  • Aquestive Therapeutics' Inventory Average (Quarter) stood at $3.5 million in 2021, then soared by 81.21% to $6.3 million in 2022, then grew by 10.74% to $6.9 million in 2023, then decreased by 5.65% to $6.5 million in 2024, then increased by 22.53% to $8.0 million in 2025.
  • Its Inventory Average was $8.0 million in Q3 2025, compared to $7.7 million in Q2 2025 and $6.6 million in Q1 2025.